gvtcx

Urolift Consumables

Chelsea & Westminster Hospital NHS Foundation Trusts Published 19 Jul 2021 Find a Tender

key details

Statuscomplete
Category (CPV) 33125000
Procedurelimited
OCIDocds-h6vhtk-02c98e

Award

SupplierValueDateStatus
Teleflex Medical · · active

description

Benign prostatic hyperplasia affects over 500 million men worldwide. While men can select from a variety of treatment options—from medication to major surgery—there has been a gap in the treatment continuum for a less invasive option.

Prostatic Urethral Lift using the UroLift® System was designed to meet this need. With its unique design and mechanism of action, the UroLift System is a straightforward treatment that provides immediate, visible results.

The procedure can be done in an outpatient or inpatient setting and under general or local anaesthesia. Patients typically can return home the same day without a catheter, and experience rapid symptom relief and recovery with low complication rates. The UroLift System treatment revitalizes the quality of life for patients and improves the BPH therapy experience for physicians.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
19 Jul 2021 Voluntary ex-ante transparency (F15) Earlier regulations 016929-2021

more from Chelsea & Westminster Hospital NHS Foundation Trusts

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Find a Tender. Contact details for named individuals are not reproduced on this site.